24-hour urinary sodium excretion

Biomarker1 paper1 finding

  • Human trial1

Interventions

1

Empagliflozin

upin humans1Low certainty

1 study
  1. Empagliflozin increases 24-hour urinary sodium excretion in humans (+92.1 mmol/24 h (95%CI: 47.1-137.2)).

    Human trialtype 2 diabetes, decompensated cirrhosis, and refractory ascites10 mg once daily10 daysn = 21

    Empagliflozin Promotes Natriuresis in Diabetic Patients with Cirrhotic Refractory Ascites: A Proof-of-Concept Study · Journal of gastrointestinal and liver diseases : JGLD · 26 Sep 2026

Empagliflozin →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 01